Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
MAXWELLIA logo — Widening access to medicines

MAXWELLIA

Widening access to medicines

Founded 2013 United Kingdom Alderley Edge, United Kingdom 10 employees Total: $5.50M Biopharma, Health Care +1

General Information

Company Name MAXWELLIA
Founded Year 2013
Location United Kingdom Alderley Edge, United Kingdom
Employees 10
Industries Biopharma, Health Care, Pharmaceutical
Social

BounceWatch is an independent company data service, not affiliated with MAXWELLIA. To contact MAXWELLIA, visit maxwellia.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does MAXWELLIA compare?

A PDF of MAXWELLIA and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting MAXWELLIA soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About MAXWELLIA

Maxwellia is a pioneering British start-up in the biopharma, health care, and pharmaceutical industries. Founded in 2013, Maxwellia's unique proposition lies in converting prescription medicines into versions available for purchase in pharmacies. The company's dedication to facilitating the safe supply of medicines under the supervision of pharmacists sets it apart. Their innovative approach aims to alleviate the burden on general practitioners by enabling individuals to manage certain conditions without the need for a doctor's appointment. With a vision to widen access to a range of widely used and effective medicines, Maxwellia's mission revolves around making these products conveniently available in local pharmacies, thus reducing the strain on an over-stretched NHS. The latest Venture Round investment in Maxwellia occurred on October 6, 2021, and the investors behind this funding round are not specified. As Maxwellia continues to innovate and develop breakthrough products, its impact in transforming the accessibility of healthcare products and services will be one to watch.

Business keywords: pharmaceuticals, over-the-counter drugs, MHRA, women's health, prescription drugs, medicine reclassification, health products, drug accessibility, public consultation, OTC market, pharmaceutical regulation

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Late VC £1.10M -
01 Jun 2025
Late VC Undisclosed 5
Catapult Ventures Praetura Ventures the UK Future Fund
Catapult Ventures, Praetura Ventures +3
01 Dec 2022
Media For Equity Undisclosed 1
Channel 4 Ventures
Channel 4 Ventures
01 Oct 2021
Early VC €3.70M 5
Catapult Ventures Praetura Ventures Future Fund
Catapult Ventures, Praetura Ventures +3
01 Apr 2021
Grant Undisclosed -
01 Jul 2020
Seed Undisclosed 5
Catapult Ventures Praetura Ventures the UK Future Fund
Catapult Ventures, Praetura Ventures +3
01 Jul 2019
Seed £700.00K 1
GM&C Life Sciences Fund
GM&C Life Sciences Fund
01 Mar 2018

MAXWELLIA Alternatives & Competitors

View All Alternatives
MAXWELLIA vs
Genus Pharmaceuticals Ltd
Genus Pharmaceuticals Ltd United Kingdom

Providing comprehensive healthcare solutions with a wide range of generic medicines and pharmacy pro...

22 employees
Health Care, Pharmaceutical
MAXWELLIA vs
Teva Canada
Teva Canada Canada

Committed to providing innovative and quality medicines | Voué à fournir des médicaments de qualité...

191 employees
Biopharma, Biotechnology
MAXWELLIA vs
Zentiva
Zentiva Czech Republic

At Zentiva, we provide health and wellbeing for all generations

3677 employees
Health Care, Manufacturing
Also compare with: MAXWELLIA vs Netmeds.com Netmeds.com View all alternatives

FAQ About MAXWELLIA

Widening access to medicines
MAXWELLIA was founded in 2013.
MAXWELLIA is headquartered in Alderley Edge, United Kingdom.
MAXWELLIA operates in Biopharma, Health Care and Pharmaceutical. Its work centres on pharmaceuticals, over-the-counter drugs, MHRA and women's health.
MAXWELLIA has approximately 10 employees.
MAXWELLIA has completed 7 funding rounds, raising a total of $5.50M.
Top alternatives and competitors to MAXWELLIA include Genus Pharmaceuticals Ltd, Teva Canada, Zentiva, Netmeds.com, Cadence OTC. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
MAXWELLIA and Genus Pharmaceuticals Ltd are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for MAXWELLIA, https://bouncewatch.com/company/maxwellia, updated 11 March 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes